ATE336490T1 - Flavon derivate, verfahren zu deren herstellung und deren verwendung als heilmittel - Google Patents
Flavon derivate, verfahren zu deren herstellung und deren verwendung als heilmittelInfo
- Publication number
- ATE336490T1 ATE336490T1 AT01909906T AT01909906T ATE336490T1 AT E336490 T1 ATE336490 T1 AT E336490T1 AT 01909906 T AT01909906 T AT 01909906T AT 01909906 T AT01909906 T AT 01909906T AT E336490 T1 ATE336490 T1 AT E336490T1
- Authority
- AT
- Austria
- Prior art keywords
- remedies
- production
- flavone derivatives
- flavone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0002528A FR2805538B1 (fr) | 2000-02-29 | 2000-02-29 | Nouveaux derives de flavones, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE336490T1 true ATE336490T1 (de) | 2006-09-15 |
Family
ID=8847520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01909906T ATE336490T1 (de) | 2000-02-29 | 2001-02-27 | Flavon derivate, verfahren zu deren herstellung und deren verwendung als heilmittel |
Country Status (16)
Country | Link |
---|---|
US (1) | US20030119816A1 (de) |
EP (1) | EP1261603B1 (de) |
JP (1) | JP5118282B2 (de) |
AR (1) | AR029479A1 (de) |
AT (1) | ATE336490T1 (de) |
AU (1) | AU783663B2 (de) |
CA (1) | CA2403424C (de) |
CY (1) | CY1105786T1 (de) |
DE (1) | DE60122295T2 (de) |
DK (1) | DK1261603T5 (de) |
ES (1) | ES2270984T3 (de) |
FR (1) | FR2805538B1 (de) |
MY (1) | MY159418A (de) |
PT (1) | PT1261603E (de) |
TW (1) | TWI282338B (de) |
WO (1) | WO2001064673A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2522827T3 (es) * | 2009-10-30 | 2014-11-18 | Domain Therapeutics | Nuevos derivados de oximas y su uso como moduladores alostéricos de los receptores del glutamato metabotrópico |
CN103896895A (zh) * | 2013-12-31 | 2014-07-02 | 浙江工业大学 | 一种香豆素衍生物的制备方法 |
WO2018094275A1 (en) * | 2016-11-18 | 2018-05-24 | Tolero Pharmaceuticals, Inc. | Alvocidib prodrugs and their use as protein kinase inhibitors |
US11497756B2 (en) | 2017-09-12 | 2022-11-15 | Sumitomo Pharma Oncology, Inc. | Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib |
KR20210099066A (ko) | 2018-12-04 | 2021-08-11 | 스미토모 다이니폰 파마 온콜로지, 인크. | 암의 치료를 위한 작용제로서 사용하기 위한 cdk9 억제제 및 그의 다형체 |
JP2022525149A (ja) | 2019-03-20 | 2022-05-11 | スミトモ ダイニッポン ファーマ オンコロジー, インコーポレイテッド | ベネトクラクスが失敗した急性骨髄性白血病(aml)の処置 |
CN111057035B (zh) * | 2019-11-05 | 2021-10-26 | 中国人民解放军第二军医大学 | 一种黄芩素衍生物及其制备方法与应用 |
GB202104122D0 (en) * | 2021-03-24 | 2021-05-05 | Floratek Pharma Ag | Compounds and their use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN164232B (de) * | 1986-04-11 | 1989-02-04 | Hoechst India | |
DE3836676A1 (de) * | 1988-10-28 | 1990-05-03 | Hoechst Ag | Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel |
US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
US5908934A (en) * | 1996-09-26 | 1999-06-01 | Bristol-Myers Squibb Company | Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs |
-
2000
- 2000-02-29 FR FR0002528A patent/FR2805538B1/fr not_active Expired - Fee Related
-
2001
- 2001-02-27 ES ES01909906T patent/ES2270984T3/es not_active Expired - Lifetime
- 2001-02-27 DE DE60122295T patent/DE60122295T2/de not_active Expired - Lifetime
- 2001-02-27 TW TWNEWDERIVA patent/TWI282338B/zh not_active IP Right Cessation
- 2001-02-27 WO PCT/FR2001/000561 patent/WO2001064673A1/fr active IP Right Grant
- 2001-02-27 US US10/181,677 patent/US20030119816A1/en not_active Abandoned
- 2001-02-27 DK DK01909906T patent/DK1261603T5/da active
- 2001-02-27 AU AU37501/01A patent/AU783663B2/en not_active Ceased
- 2001-02-27 EP EP01909906A patent/EP1261603B1/de not_active Expired - Lifetime
- 2001-02-27 JP JP2001563513A patent/JP5118282B2/ja not_active Expired - Fee Related
- 2001-02-27 PT PT01909906T patent/PT1261603E/pt unknown
- 2001-02-27 CA CA2403424A patent/CA2403424C/fr not_active Expired - Fee Related
- 2001-02-27 AT AT01909906T patent/ATE336490T1/de active
- 2001-02-27 MY MYPI20010863A patent/MY159418A/en unknown
- 2001-02-28 AR ARP010100941A patent/AR029479A1/es not_active Application Discontinuation
-
2006
- 2006-11-15 CY CY20061101663T patent/CY1105786T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK1261603T3 (da) | 2006-12-27 |
CY1105786T1 (el) | 2011-02-02 |
CA2403424A1 (fr) | 2001-09-07 |
AU783663B2 (en) | 2005-11-24 |
AR029479A1 (es) | 2003-07-02 |
EP1261603B1 (de) | 2006-08-16 |
TWI282338B (en) | 2007-06-11 |
PT1261603E (pt) | 2007-01-31 |
FR2805538A1 (fr) | 2001-08-31 |
MY159418A (en) | 2017-01-13 |
US20030119816A1 (en) | 2003-06-26 |
AU3750101A (en) | 2001-09-12 |
DE60122295T2 (de) | 2007-11-15 |
DE60122295D1 (de) | 2006-09-28 |
WO2001064673A1 (fr) | 2001-09-07 |
JP5118282B2 (ja) | 2013-01-16 |
FR2805538B1 (fr) | 2006-08-04 |
ES2270984T3 (es) | 2007-04-16 |
JP2003525290A (ja) | 2003-08-26 |
EP1261603A1 (de) | 2002-12-04 |
DK1261603T5 (da) | 2007-07-09 |
CA2403424C (fr) | 2011-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50312949D1 (de) | Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung | |
ATE263754T1 (de) | Substituierte sulfonylaminomethylbenzoesäure(derivate) und verfahren zu ihrer herstellung | |
ATE370946T1 (de) | 16-halogen-epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung | |
ATE302754T1 (de) | Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE332898T1 (de) | Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
DE60033028D1 (de) | 5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung | |
ATE265424T1 (de) | Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE348609T1 (de) | Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
ATE327981T1 (de) | Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel | |
ATE482193T1 (de) | Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen | |
ATE346065T1 (de) | Substituierte thiazol- benzoisothiazoldioxidderivative, verfahren zu deren herstellung und deren verwendung | |
DE50011179D1 (de) | Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE336490T1 (de) | Flavon derivate, verfahren zu deren herstellung und deren verwendung als heilmittel | |
DE10081263D2 (de) | Schraubverbindung und Verbindungsmittel hierfür sowie Verfahren zu deren Herstellung | |
DE50310320D1 (de) | Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung | |
DE60205717D1 (de) | 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
DE69908371D1 (de) | Thioethergruppen enthaltende distamycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
DE50110363D1 (de) | Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben | |
DE60015806D1 (de) | Poly-3-cyclopropyl-3-hydroxypropionat und verfahren zu seiner herstellung und derivate daraus | |
DE502004007668D1 (de) | Substituierte 3-(benzoylureido)-thiophenderivate, verfahren zu deren herstellung und deren verwendung | |
DE60210595D1 (de) | Neue 5-thio-ss-d-xylopyranosidderivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen und deren therapeutische verwendung | |
DE50203198D1 (de) | Caloporosid-derivate, verfahren zu deren herstellung und deren verwendung | |
DE59905337D1 (de) | Steroidhaltiges pflaster, verfahren zu seiner herstellung und verwendung | |
DE50213487D1 (de) | C2-substituierte indan-1-ole und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE327227T1 (de) | Klainetine und ihre derivate, verfahren zu ihrer herstellung und verwendung derselben |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1261603 Country of ref document: EP |